Page 78 - 南京医科大学学报自然科学版
P. 78

南京医科大学学报(自然科学版)                                  第43卷第6期
               ·820 ·                     Journal of Nanjing Medical University(Natural Sciences)   2023年6月


             ·临床研究·

              单纯靶向活检与靶向联合系统活检在高 PI⁃RADS 评分患者中

              的对比研究



              龙   宇,王宇昊,周天任,丁 磊,梁 超 ,李                  杰 *
                                                  *
              南京医科大学第一附属医院泌尿外科,江苏 南京                   210029






             [摘    要] 目的:比较前列腺单纯靶向活检与靶向联合系统活检对前列腺影像报告和数据系统(prostate imaging reporting and
              data system,PI⁃RADS)评分4~5分患者的诊断效能。方法:回顾性分析2019年7月1日—2022年6月1日南京医科大学第一附
              属医院泌尿外科439例前列腺PI⁃RADS评分为4~5分且接受前列腺单纯靶向活检与靶向联合系统活检患者的临床资料。分别
              由2名泌尿外科医生独立对每例患者行双参数磁共振成像经直肠超声(biparametric magnetic resonance imaging⁃transrectal ultra⁃
              sonography,bpMRI⁃TRUS)辅助靶向活检和靶向联合系统活检。通过χ 检验或Fisher精确检验比较不同活检方式对临床有意义
                                                                   2
              前列腺癌(clinically significant prostate cancer,CsPCa)的检出情况。结果:靶向活检对CsPCa的检出率低于靶向联合系统活检,
              但差异无统计学意义(P=0.05),如仅行单纯靶向活检,会有 5.0%的 CsPCa 被漏诊。当 PI⁃RADS 评分为 4 分时,靶向活检对
              CsPCa的检出率低于靶向联合系统活检,差异有统计学意义(P<0.05),如仅行单纯靶向活检,会有6.2%的CsPCa被漏诊。当
              0<PSA ≤20 ng/mL时,靶向活检对CsPCa的检出率低于靶向联合系统活检,差异有统计学意义(P<0.05);而 20 ng/mL<PSA ≤
              50 ng/mL时,二者差异无统计学意义(P>0.05)。当PI⁃RADS评分为5分时,靶向活检对CsPCa的检出率低于靶向联合系统活
              检,但差异无统计学意义(P>0.05),如仅行单纯靶向活检,会有3.5%的CsPCa被漏诊;在PSA亚组分析中,二者CsPCa的检出
              率差异也均无统计学意义(P>0.05)。靶向活检与根治性术后病理的符合率略低于靶向联合系统活检,但差异无统计学意义
             (P>0.05);在PI⁃RADS评分亚组及PSA分层分析中,二者病理符合率的差异也均无统计学意义(P>0.05)。结论:PI⁃RADS评分
              为4~5分疑似高危前列腺癌的患者,当PI⁃RADS评分4分且PSA>20 ng/mL或PI⁃RADS评分5分时,靶向活检可取代靶向联合系
              统活检。
             [关键词] 前列腺肿瘤;双参数磁共振;靶向活检;靶向联合系统活检
             [中图分类号] R737.25                  [文献标志码] A                        [文章编号] 1007⁃4368(2023)06⁃820⁃08
              doi:10.7655/NYDXBNS20230611


              A comparative study of targeted biopsy alone and targeted combined system biopsy in
              patients with high PI⁃RADS scores

                                                                      *
              LONG Yu,WANG Yuhao,ZHOU Tianren,DING Lei,LIANG Chao ,LI Jie   *
              Department of Urology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China


             [Abstract] Obiective:The current study aims to compare the diagnostic efficacy of prostate targeted biopsy alone and targeted
              combined system biopsy in patients with high prostate imaging reporting and data system(PI⁃RADS)score of 4~5. Methods:
              Between July 1,2019 and June 1,2022,439 patients with prostate PI⁃RADS score of 4⁃5 who received prostate targeted biopsy alone
              and targeted combined system biopsy in the First Affiliated Hospital of Nanjing Medical University were retrospectively analyzed. Two
              urologists independently performed biparametric magnetic resonance imaging ⁃ transrectal ultrasonography(bpMRI ⁃ TRUS)assisted
              targeted biopsy and targeted combined system biopsy in each patient. The detection of clinically significant prostate cancer(CsPCa)by
                                               2
              different biopsy methods were compared by χ test or Fisher’s exact test. Results:The detection rate of CsPCa by targeted biopsy was
             [基金项目] 国家自然科学基金(82002718,81672532);江苏省自然科学基金(BK20191077);江苏省人民医院临床能力提升
              工程项目(JSPH⁃MC⁃2021⁃12)
              ∗
              通信作者(Corresponding author),E⁃mail:drc_lijie@126.com;lc_machine@163.com
   73   74   75   76   77   78   79   80   81   82   83